Philip Wenzel: The Role of MyD88 in the Inflammatory Transition from Hypertension to Heart Failure
Philip Wenzel, Director of the Medical Clinic I, Darmstadt Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“After so many years in the making, our paper is finally out!
Very proud to have it published as editor’s choice in EHJOpen… starting off as Sabine’s PhD thesis, it evolved into a truely translational project spanning from genetic mouse models to a GWAS of 15y follow-up to pinpoint the role of MyD88 for the inflammatory transition from Hypertension to Heart Failure.
Enjoy the read!”
Title: MyD88 in myeloid cells drives angiotensin II-induced vascular inflammation, is associated with prevalent heart failure and predicts all-cause mortality in arterial hypertension
Authors: Sabine Wild, Stefanie Finger, Andreas Schulz, Melania Aluia, Jimena Bravo, Rahul Kumar, Jeremy Lagrange, Gregorio Alanis-Lobato, Voahanginirina Randriamboavonjy, Johannes Wild, Michael Molitor, Christian Müller, Tanja Zeller, Alexander Gieswinkel, Andreas Daiber, Susanne Karbach, Marcus Dörr, Ingrid Fleming, Philipp Lurz, Thomas Münzel, Markus Radsak, Katrin Schäfer, Daniela S Krause, Miguel A Andrade-Navarro, Philipp Wild, Philip Wenzel
Read the Full Article on European Heart Journal Open

Stay updated with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids